BP333

Tobramycin

British Pharmacopoeia (BP) Reference Standard

• Synonym(e): O-[3-Amino-3-deoxy-α-D-glucopyranosyl-(1→6)]-O-[2,6-diamino-2,3,6-trideoxy-α-D-ribohexopyranosyl-(1→4)]-2-deoxy-D-streptamin, Nebramycin Faktor 6
• Empirische Formel (Hill-System): C₁₈H₃₇N₅O₉
• CAS-Nummer: 32986-56-4
• Molekulargewicht: 467.51
• NACRES: NA.24
• UNSPSC Code: 41116107
• Beilstein/REAXYS Number: 1357507
• MDL number: MFCD00077885

Eigenschaften

• grade: pharmaceutical primary standard
• API family: tobramycin
• form: solid
• shelf life: limited shelf life, expiry date on the label
• manufacturer/tradename: BP
• application(s): pharmaceutical; pharmaceutical small molecule
• format: neat
• storage temp.: 2-8°C
• SMILES string: NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O
• InChI: 1S/C18H37N5O9/c19-3-9-8(25)2-7(22)17(29-9)31-15-5(20)1-6(21)16(14(15)28)32-18-13(27)11(23)12(26)10(4-24)30-18/h5-18,24-28H,1-4,19-23H2/t5-,6+,7+,8-,9+,10+,11+,12+,13+,14-,15+,16-,17+,18+/m0/s1
• InChI key: NLVFBUXFDBBNBW-SNGYORCQSA-N

Beschreibung

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support

Application

Tobramycin BP Reference standard, intended for use in laboratory tests only as specifically prescribed in the British Pharmacopoeia.

Also used in monographs such as:

Tobramycin and Dexamethasone Eye Drops, Suspension

Apramycin Premix

Tobramycin Inhalation Powder, Hard Capsule

Apramycin Sulfate

Tobramycin Nebuliser Solution

Tobramycin Oral Solution

Tobramycin Eye Drops

Tobramycin Injection

Tobramycin Sulfate

Apramycin Veterinary Oral Powder

Biochem/physiol Actions

Tobramycin ist ein Aminoglykosid.
Wirkungsweise: Bindet an die 70S ribosomale Untereinheit; hemmt die Translokation; löst Fehlcodierung aus.
Wirkspektrum: gram-negative Bakterien. Nicht wirksam gegen Enterokokken

Packaging

Unit quantity: 350 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia

Other Notes

Sales restrictions may apply.

Sicherheitshinweise

• pictograms: GHS08
• signalword: Warning
• hcodes: H361f
• pcodes: P201 - P202 - P280 - P308 + P313 - P405 - P501
• Hazard Classifications: Repr. 2
• Lagerklasse: 11 - Combustible Solids
• wgk: WGK 3